Approximately 40% of the population (n = 70, 38.9%) had a HER2 0 disease, the remaining 61.1% (n = 110) had a HER2 low (i.e. 1+ or HER2 2+ with a negative FISH test) tumor. The gene discussed is ERBB2; the disease is neoplasm.